Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

NCT04023344 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Diabetes Mellitus

Interventions

DRUG: Humalog Mix25
DRUG: Insulin Lispro Biphasic 25

Sponsor

Geropharm